Porphyrinogenicity of certain xenobiotics depends upon mechanism-based inactivation of specific cytochrome P450 (P450) enzymes, followed by formation of N-alkylprotoporphyrin IX (N-alkylPP). Examination of the porphyrinogenicity of xenobiotics in animals and extrapolation of the results to humans is associated with ambiguity due, in part, to differences between P450 enzymes. The goal of this study was to develop an in vitro test for the detection of N-alkylPPs, produced in human liver after administration of xenobiotics found to be porphyrinogenic in animals. This goal was achieved using fluorometry to detect N-alkylPP formation following mechanism-based inactivation by porphyrinogenic xenobiotics of single cDNA-expressed human P450 enzymes in microsomes prepared from baculovirus-infected insect cells ( Xenobiotics which interfere with control of heme biosynthesis and allow porphyrins to accumulate are referred to as porphyrinogenic. The porphyrinogenic effects of several xenobiotics (e.g., TTMS 1 , 4-ethyl DDC, and AIA) depend on their ability to cause mechanismbased inactivation of P450 enzymes (Ortiz de Montellano et al., 1981a; Ortiz de Montellano and Grab, 1986; Oritz de Montellano and Mico, 1981c). These xenobiotics, upon selective P450 enzyme mediated biotransformation, form reactive intermediates at the P450 active site. The reactive intermediates interact with the heme moiety resulting in N-alkylation of a pyrrole ring (Marks et al., 1988; Ortiz de Montellano and Correia, 1995) . P450 inactivation and dissociation of N-alkylheme is followed by loss of iron, yielding N-alkylprotoporphyrin IX (N-alkylPP), some of which are potent inhibitors of ferrochelatase (EC 4.99.1.1) (De Matteis et al., 1980; Cole et al., 1981) . Ferrochelatase inhibition results in decreased heme production and less control over the rate-limiting enzyme aminolevulinic acid synthase (EC 2.3.1.37; aminolevulinic acid synthase). Increased aminolevulinic acid synthase activity results in porphyrin accumulation and porphyria (De Matteis and Marks, 1996) . The N-alkylPP formed after mechanism-based inactivation of P450 by AIA, viz. N-AIAPP 2 , does not inhibit ferrochelatase. The porphyrinogenic effect of AIA is explained as follows: since P450 can be reconstituted after undergoing mechanism-based inactivation by AIA as a result of the exchange of the N-alkylated heme moiety (N-AIAPP) for a fresh heme molecule, AIA functions as a heme-destructive catalyst that depletes regulatory free heme (Ortiz de Montellano et al., 1985) .
Xenobiotics which interfere with control of heme biosynthesis and allow porphyrins to accumulate are referred to as porphyrinogenic. The porphyrinogenic effects of several xenobiotics (e.g., TTMS 1 , 4-ethyl DDC, and AIA) depend on their ability to cause mechanismbased inactivation of P450 enzymes (Ortiz de Montellano et al., 1981a; Ortiz de Montellano and Grab, 1986; Oritz de Montellano and Mico, 1981c) . These xenobiotics, upon selective P450 enzyme mediated biotransformation, form reactive intermediates at the P450 active site. The reactive intermediates interact with the heme moiety resulting in N-alkylation of a pyrrole ring (Marks et al., 1988; Ortiz de Montellano and Correia, 1995) . P450 inactivation and dissociation of N-alkylheme is followed by loss of iron, yielding N-alkylprotoporphyrin IX (N-alkylPP), some of which are potent inhibitors of ferrochelatase (EC 4.99.1.1) (De Matteis et al., 1980; Cole et al., 1981) . Ferrochelatase inhibition results in decreased heme production and less control over the rate-limiting enzyme aminolevulinic acid synthase (EC 2.3.1.37; aminolevulinic acid synthase). Increased aminolevulinic acid synthase activity results in porphyrin accumulation and porphyria (De Matteis and Marks, 1996) . The N-alkylPP formed after mechanism-based inactivation of P450 by AIA, viz. N-AIAPP 2 , does not inhibit ferrochelatase. The porphyrinogenic effect of AIA is explained as follows: since P450 can be reconstituted after undergoing mechanism-based inactivation by AIA as a result of the exchange of the N-alkylated heme moiety (N-AIAPP) for a fresh heme molecule, AIA functions as a heme-destructive catalyst that depletes regulatory free heme (Ortiz de Montellano et al., 1985) .
The porphyrinogenicity of TTMS, 4-ethyl DDC, and AIA, has been shown in animals to be dependent on mechanism-based inactivation of specific P450 enzymes (Marks et al., 1988) . Our previous in vivo studies have elucidated the important rat liver P450 enzymes responsible for N-alkylPP formation. CYP3A2 is the major source of Nvinylprotoporphyrin IX (N-vinylPP) after the administration of TTMS to rats whereas CYP2C11 is the major source of N-ethylprotoporphyrin IX (N-ethylPP) and N-AIAprotoporphyrin IX (N-AIAPP) after the administration of 4-ethyl DDC and AIA, respectively (Wong et al., 1998 (Wong et al., , 1999a .
Currently during toxicity testing, the porphyrinogenicity of xenobiotics is tested in animals, and it is sometimes a problem to relate these results to humans. In the case of xenobiotics, which owe their porphyrinogenicity to mechanism-based inactivation of selective P450 enzymes with formation of N-alkylPPs, the problem stems, in part, to differences in the P450 enzymes between animals and humans. This is a particular problem when a xenobiotic is found to be porphyrinogenic in one species but not in others (Frater et al., 1993) . Therefore, an understanding of the human P450 enzymes targeted by these xenobiotics is required to establish whether porphyria elicited in animals is likely to occur in humans. Using microsomes prepared from human lymphoblastoid cell lines containing single cDNA-expressed human P450 enzymes, McNamee et al. (1997) used selective enzyme activities to determine which human P450 enzymes are susceptible to mechanism-based inactivation after administration of TTMS, 4-ethyl DDC, and AIA. TTMS and 4-ethyl DDC caused mechanism-based inactivation of human P450 enzymes 1A2 and 3A4, whereas only 4-ethyl DDC caused mechanism-based inactivation of CYP2C9; neither xenobiotic caused mechanism-based inactivation of CYP2D6. AIA did not inactivate any of the human P450 enzymes. However, there are several different ways in which xenobiotics can cause mechanism-based inactivation, and hepatic porphyrin accumulation will only occur if N-alkylPP formation accompanies mechanism-based inactivation (Marks et al., 1988) . Therefore, it is important to determine which human P450 enzymes targeted for mechanismbased inactivation also elicit N-alkylPP formation.
In previous studies, we determined that interaction of porphyrinogenic xenobiotics with in vitro preparations containing hepatic P450 enzymes in quantities similar to those in commercially available microsomal products from human lymphobastoid cells (0.5-1.0 nmol total P450) did not yield N-alkylPPs in sufficient quantity to be detected by a combination of thin-layer chromatography and UVvisible spectrophotometry (Wong and Marks, 1999b) . Our primary goal is the development of an in vitro test system for the isolation and detection of N-alkylPPs, which may be produced in human liver after administration of xenobiotics, previously found to be porphyrinogenic in animals. We therefore explored a variety of methods to determine which was sufficiently sensitive for the detection of N-alkylPP formation from in vitro preparations containing human hepatic P450 enzymes. Our first objective was to use the most sensitive method to determine which specific P450 enzymes were responsible for NalkylPP formation using single cDNA-expressed human P450 enzymes in microsomes prepared from baculovirus-infected insect cells (Supersomes). The second objective was to use the most sensitive method to determine whether N-alkylPP formation could be detected in human liver microsomes after interaction with xenobiotics in vitro.
Materials and Methods
Source of Chemicals. TTMS and 4-ethyl DDC were obtained from Color Your Enzyme (Bath, Ontario, Canada). AIA was obtained as a gift from F. Hoffman-LaRoche (Vaudreuil, Quebec, Canada). Solvents (acetone, dichloromethane, and methanol) were purchased from VWR Canada (Mississauga, Ontario, Canada). Inducers (␤-naphthoflavone, dexamethasone, and phenobarbital sodium) and NADPH were purchased from Sigma-Aldrich (St. Louis, MO). Human liver microsomes and Supersomes were purchased from Gentest Corp. (Woburn, MA).
Treatment of Animals. Male Sprague-Dawley rats (250 to 300 g) were obtained from Charles River Canada, Inc. (St. Constant, Quebec, Canada). All rats received Purina Laboratory Chow (Purina, St. Louis, MO) and water ad libitum and were housed under controlled conditions (22°C, 14:10 h light/dark cycle) prior to treatment.
Treatment of Male Rats with P450 Inducers. Rats received either dexamethasone (100 mg/kg, dissolved in 0.5 ml dimethyl sulfoxide) or phenobarbital sodium (80 mg/kg, dissolved in 0.5 ml deionized water) administered i.p. once daily for 4 days. ␤-Naphthoflavone (40 mg/kg, dissolved in 0.5 ml dimethyl sulfoxide) was administered i.p. once daily for 3 days (McNamee et al., 1997) .
Preparation of Rat Hepatic Microsomes. Twenty-four hours after final treatment with specific P450 enzyme inducer, rats were sacrificed by decapitation, and their livers were perfused in situ with 150 ml of ice-cold 1.15% (w/v) KCl to remove the blood. Livers were excised, then minced and homogenized in 3 volumes of ice-cold phosphate-buffered KCl [1.15% (w/v) KCl, 10 mM K 2 HPO 4 , pH 7.4] using a Potter-Elvehjem apparatus. The homogenate was centrifuged at 9000g for 20 min. The supernatant was centrifuged at 106,000g for 60 min at 4°C. The resulting eight microsomal pellets were resuspended in ice-cold 0.1 M K 2 HPO 4 buffer (pH 7.4) containing 1.5 mM EDTA and recentrifuged at 106,000g for 60 min at 4°C. Each microsomal pellet was resuspended in 4.0 ml of 0.1 M K 2 HPO 4 buffer (pH 7.4) containing 1.5 mM EDTA to yield a protein concentration of 4 to 6 mg/ml (Wong and Marks, 1999b) . Microsomal P450 content was determined on 1 ml of microsomal suspension prior to mechanism-based inactivation by the difference spectrophotometric method of Omura and Sato (1964) .
Mechanism-Based Inactivation of Rat Hepatic Microsomal P450 with Porphyrinogenic Xenobiotics. For studies with TTMS, 4-ethyl DDC, and AIA, liver microsomal suspensions from dexamethasone-, ␤-naphthoflavone-, or phenobarbital-pretreated rats were used, respectively. Microsomal suspensions were incubated with 2.0 mM NADPH and TTMS (0.5 mM), 4-ethyl DDC (1.0 mM), or AIA (10 mM) for 30 min at 37°C in a shaking water bath. When one microsomal pellet was used, the final volume was 4 ml. With consecutive reductions in amount of microsomes used, the final volume was reduced in a corresponding manner.
Isolation of N-alkylPP from Rat Hepatic Microsomes. Following incubation, the reaction mixture (4 ml) was mixed with 5 volumes of ice-cold 5% H 2 SO 4 :methanol (v/v) (20 ml) and shaken in the dark at 4°C for 18 h. The mixture containing N-alkylPP dimethyl esters was filtered, diluted with an equal volume of deionized water (24 ml), and then extracted twice with dichloromethane (2 ϫ 12 ml) in a separatory funnel. The dichloromethane extract was washed with 5% sodium bicarbonate (24 ml). Zinc acetate (12 mol) in 1.0 ml methanol was added to the dichloromethane solution to form the Zn N-alkylPP dimethyl ester, and the solution was evaporated to dryness. The N-alkylPP dimethyl ester forms complexes with a variety of metals leading to the formation of a mixture of metallo-complexes, particularly during TLC. Preparation of the zinc complex circumvents this problem. The residue was dissolved in dichloromethane (3 ml), and an aliquot (1 ml) was taken for UV-visible spectrophotometry, and an aliquot (2 ml) was taken for fluorometry (see below). The dichloromethane aliquots were combined and applied to an Analtec silica gel G TLC plate (2000 m; Analtech, Newark, DE) and developed in dichloromethane/methanol (195:30) for 60 min. A single green band (R f 0.68 -0.74) that fluoresced red under long wavelength ultraviolet light was eluted from the plate with acetone and evaporated to dryness under nitrogen, as previously described by Wong and Marks (1999b) . The residue was dissolved in dichloromethane (1.0 ml) for both UV-visible spectrophotometry and fluorometry.
Quantitation of Zn N-alkylPP Dimethyl Ester by UV-Visible Spectrophotometry and Fluorometry prior to and following TLC. The electronic absorption spectrum of the Zn N-alkylPP dimethyl ester in dichloromethane (1.0 ml) was determined, and the Zn N-alkylPP dimethyl ester concentration was calculated using the molar extinction coefficient of 128,000 m Ϫ1 cm Ϫ1 at 432 nm (Ortiz de Montellano et al., 1981b) . The dichloromethane solution (1.0 ml) was diluted with 1.0 ml of dichloromethane, and the fluorescence spectrum of the Zn N-alkylPP dimethyl ester in dichloromethane was determined. Using an excitation wavelength of 432 nm (Soret band), the emission spectrum of the sample was scanned from 600 to 800 nm. The emission spectrum characteristics of samples containing Zn NalkylPP dimethyl esters included peaks at 660 and 720 nm for N-vinylPP, 655 and 715 nm for N-ethylPP, and 650 and 712 nm for N-AIAPP. The Zn N-alkylPP dimethyl ester concentration was determined from standard curves obtained by using known concentrations determined by UV-visible spectrophotometry.
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Mechanism-Based Inactivation of Human P450 Enzymes in Supersomes with Porphyrinogenic Xenobiotics. Microsomes prepared from baculovirus-infected insect cells (Supersomes) possessing single cDNA-expressed human P450 enzymes (1A2, catalogue no. P203; 2C9, catalogue no. P258; 2D6, catalogue no. P217; or 3A4, catalogue no. P202) were obtained from Gentest Corp. All Supersomes were prepared from cell lines coexpressing P450 and oxidoreductase cDNA. Following previously described methods (McNamee et al., 1997) , when required, Supersomes were rapidly thawed in a 37°C shaking water bath. The Supersomes suspension (1.0 ml for CYP1A2, 2C9, and 2D6 and 0.5 ml for CYP3A4) was added to 5-ml Erlenmeyer flasks, containing 2.0 mM NADPH and TTMS (0.5 mM), 4-ethyl DDC (1.0 mM), or AIA (10 mM). Samples were incubated for 30 min in a 37°C shaking water bath.
Isolation of N-alkylPP from Supersomes Containing CYP1A2, 2C9, 2D6, and 3A4. Following incubation, the reaction mixture was mixed with 5 volumes of ice-cold 5% H 2 SO 4 :methanol (v/v) (5 ml) and shaken in the dark at 4°C for 18 h. The mixture containing N-alkylPP dimethyl esters was filtered, diluted with an equal volume of deionized water (6 ml), and then extracted twice with dichloromethane (2 ϫ 3 ml) in a 60-ml separatory funnel. The dichloromethane extract was washed with 5% sodium bicarbonate (6 ml). Zinc acetate (12 mol) in 1.0 ml of methanol was added to the dichloromethane solution to form the Zn N-alkylPP dimethyl ester. The volume of solution was reduced to 2 ml by a stream of nitrogen prior to fluorometric quantitation. Since the Supersome preparation of CYP3A4 was contained in a volume of 0.5 ml, the above procedure was carried out by reducing volumes of reagents by 50%. Wherever the presence of an N-alkylPP was detected, the experiment was repeated with a second Supersome preparation.
Mechanism-Based Inactivation of Human P450 Enzymes in Human Liver Microsomes and Isolation of N-alkylPP. The procedure described above for Supersomes was used for human liver microsomes, which were also obtained from Gentest Corp. Human liver microsomes possessing elevated CYP3A4 (catalogue no. HG112) contained 6.28 nmol of total P450 in 0.5 ml, of which 53% was CYP3A4, 14% CYP2C9, 7.5% CYP2B6, 11.5% CYP2C19, 1.2% CYP2D6, and 11.2% CYP2E1. The human liver microsomes were obtained from a two-year-old white female who had died of head trauma. During hospitalization, she had received mannitol, phenytoin, ibuprofen, nafcillin, phenobarbital, ranitidine, dobutaine, dopamine, and lorazepam. Human liver microsomes possessing elevated CYP1A2 and CYP2C9 (catalogue no. HG56) contained 4.98 nmol of total P450 of which 25% was CYP1A2, 29% CYP2C9, 12.5% CYP3A4, 11.6% CYP2A6, 5% CYP2C19, 2.2% CYP2D6, and 13.2% CYP2E1. The human liver microsomes were obtained from a 57-year-old white female who had died of an aneurism. Her medical history included hypertension and hepatitis A. Medication given during hospitalization was not available. Whenever an N-alkylPP was detected, the experiment was repeated with a second batch of human liver microsomes with the same catalogue number.
Results and Discussion
To achieve our primary goal, namely to develop an in vitro test system for the isolation and detection of N-alkylPPs, which may be produced in the human liver after administration of xenobiotics, our first studies were directed to establishing a sensitive technique for detecting N-alkylPP formation.
Isolation and Detection of N-alkylPPs Formed in Rat Liver Microsomes. The lower limit of detection (LLD) of N-alkylPPs by UV-visible spectrophotometry and fluorometry was determined, using known amounts of N-alkylPP in dichloromethane. The LLD was determined by setting the criterion that the peak heights were at least 1.5 times greater than that of the noise level. The fluorometer cuvettes required 2 ml of solution as compared with the spectrophotometer cuvettes, which required 1 ml. The LLD for UV-visible spectrophotometry was found to be 0.16 nmol/ml of N-alkylPP, whereas fluorometry detected as little as 0.04 nmol/2 ml of N-alkylPP. Therefore, it was concluded that fluorometry has greater sensitivity than UVvisible spectrophotometry for detection of N-alkylPP.
To determine which of four methods was the most sensitive, rat liver microsomal suspensions were incubated with NADPH and TTMS for 30 min at 37°C, and N-vinylPP formation was quantified by each of the four methods. The first method explored (UV-visible spectrophotometry without N-alkylPP isolation by TLC) could not be relied upon for N-vinylPP quantitation because the mixture, prior to TLC, still contained impurities with absorbencies that masked the characteristic spectrum of N-vinylPP. On the other hand, fluorometry without TLC could be relied upon to quantitate N-vinylPPs in this mixture, prior to TLC. Using the Soret peak of 432 nm as the excitation wavelength, the N-vinylPP emission spectrum displayed two peaks at approximately 660 and 720 nm, which were not subject to interference by other components in the mixture. While TLC could separate N-alkylPPs from interfering components in the mixture, the procedure results in a 60 to 70% loss of N-alkylPP, and we concluded that since fluorometry could be used without losses incurred by TLC, fluorometry alone was the most sensitive method for the detection of N-alkylPPs formed in vitro.
To determine whether the isolation and detection of N-alkylPPs from in vitro preparations containing human hepatic P450 enzymes was feasible for future studies, we determined the minimum amount of P450 required for the detection of N-alkylPP using fluorometry without TLC. We determined the lowest amount of P450 required to produce a detectable amount of N-vinylPP by using the LLD for fluorometry (0.04 nmol/2 ml) and interpolating the value from the graph. TTMS was able to elicit detectable N-vinylPP formation from rat hepatic liver microsomes prepared from dexamethasone-treated liver (0.01 g), containing 0.2 nmol of total P450 (Fig. 1) . For NethylPP and N-AIAPP detection, after the administration of 4-ethyl DDC and AIA, respectively, we required rat liver microsomes containing approximately 0.5 and 1.0 nmol of total P450. Since, commercially available microsomal products (Gentest Supersomes) contain 0.5 to 1.0 nmol human P450 enzyme, we concluded that these in vitro preparations contained sufficient P450 for use in detecting N-alkylPP formation following mechanism-based inactivation by porphyrinogenic xenobiotics.
Isolation and Detection of N-alkylPP from Microsomes Prepared from Baculovirus-Infected Insect Cells Possessing Single cDNA-Expressed P450 Enzymes. The most abundantly expressed P450 enzymes of the human liver are 1A2, 2C9, 2D6, and 3A4, and these enzymes are responsible for the biotransformation of most drugs that undergo P450-mediated metabolism in the human liver
FIG. 1. N-vinylPP formation as a function of the amount of cytochrome P450 present in dexamethasone-induced rat liver microsomes.
The minimum amount of total P450 required to produce detectable amounts of N-vinylPP was 0.2 nmol using the LLD for fluorometry (0.04 nmol). CYP, cytochrome P450.
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at ASPET Journals on July 7, 2017 dmd.aspetjournals.org (Guengerich, 1995) . Mechanism-based inactivation of P450 can involve a number of different pathways. However, with respect to hepatic porphyria, only the inactivation of those P450 enzymes which undergo N-alkylation are relevant. The formation of N-vinylPP, NethylPP, and N-AIAPP all lead to porphyrin accumulation. Therefore, our first objective was to identify the specific human P450 enzymes responsible for N-alkylPP formation after interaction with TTMS, 4-ethyl DDC, and AIA.
In our earlier studies, we used microsomes prepared from human lymphoblastoid cell lines containing single cDNA-expressed human P450 enzymes to determine which P450 enzymes are susceptible to mechanism-based inactivation by porphyrinogenic xenobiotics (McNamee et al., 1997) . Since that time, microsomes from baculovirusinfected insect cells possessing single cDNA-expressed P450 enzymes (Supersomes) became available. We elected to use the microsomes from the baculovirus-infected insect cells because commercial preparations contained considerably higher amounts of P450 than the microsomes from the lymphoblastoid cells, thus enhancing the potential for formation of N-alkylPP from the heme moiety of P450. We believed that the change from a lymphoblastoid cell preparation to a baculovirus-infected insect cell preparation was justifiable since our major goal was to detect N-alkylPP formation in an in vitro system. We recognize that differences would be anticipated between these two systems for a variety of reasons (e.g., a difference in the P450 to P450 reductase ratio). Thus, microsomes prepared from baculovirus-infected insect cells (Supersomes) possessing single cDNA-expressed human P450 enzymes (1A2, 2C9, 2D6, or 3A4) were incubated with TTMS, 4-ethyl DDC, and AIA, plus NADPH, and N-alkylPP formation was quantitated using fluorometry. Controls included both the omission of NADPH or porphyrinogenic xenobiotic from each of the four different human P450s.
When TTMS (0.5 mM), 4-ethyl DDC (1.0 mM), or AIA (1.0 or 10 mM) were incubated in vitro with Supersomes possessing cDNAexpressed human CYP1A2, only 4-ethyl DDC elicited N-alkylPP formation in an NADPH-dependent manner (Figs. 2 and 3) . The average ratio of N-ethylPP formation to the amount of CYP1A2 present in Supersomes (nmol/nmol) was found to be 0.60 (ratio of first trial ϭ 0.94 and ratio of second trial ϭ 0.25). The above results indicate that N-ethylPP formation occurred concurrently with mechanism-based inactivation of CYP1A2 in the microsomes from baculovirus-infected insect cells. The fact that neither TTMS nor AIA elicited N-alkylPP formation indicates that neither TTMS nor AIA caused mechanism-based inactivation of CYP1A2, or if they do, then mechanism-based inactivation takes place by a pathway other than N-alkylation of one of the pyrrole rings. These results correspond with results obtained by Wong et al. (1998 Wong et al. ( , 1999a ) using rat liver microsomes from ␤-naphthoflavone-pretreated rats in which 4-ethyl DDC but not TTMS or AIA yielded N-alkylPP formation from CYP1A1/2 (Table 1) .
4-Ethyl DDC (1.0 mM) and AIA (1.0 or 10 mM) were able to elicit N-ethylPP and N-AIAPP formation, respectively, upon interaction with Supersomes containing cDNA-expressed human CYP2C9 in an NADPH-dependent manner; on the other hand, TTMS did not elicit N-vinylPP formation (Fig. 2) . The average ratio of N-alkylPP formation to CYP2C9 present in Supersomes (nmol/nmol) was found to be 0.29 (ratio of first trial ϭ 0.39 and ratio of second trial ϭ 0.16) and 0.21 (ratio of first trial ϭ 0.26 and ratio of second trial ϭ 0.16) when incubated with 4-ethyl DDC (1.0 mM) and AIA (10 mM), respectively.
These results indicate that N-ethylPP and N-AIAPP formation occurred concurrently with mechanism-based inactivation of CYP2C9 in the microsomes from baculovirus-infected insect cells. The fact that TTMS did not elicit N-vinylPP formation indicates that TTMS either did not cause mechanism-based inactivation of CYP2C9, or if it did, then mechanism-based inactivation takes place by a pathway other than N-alkylation of one of the pyrrole rings. It is of interest to compare these results with results previously obtained with CYP2C enzymes in rats in which both rat CYP2C11 and CYP2C6 have been shown to be enzymes responsible for N-ethylPP and N-AIAPP formation, whereas CYP2C11 but not CYP2C6 was responsible for N-vinylPP formation (Table 1) . Thus, the interaction between TTMS and human CYP2C9 resembles that between TTMS and rat CYP2C6 but not rat CYP2C11.
When TTMS (0.5 mM), 4-ethyl DDC (1.0 mM), or AIA (10 mM) were incubated in vitro with Supersomes possessing cDNA-expressed human CYP2D6, N-alkylPP formation was clearly observed with AIA (Figs. 2 and 3) , and the ratio of N-AIAPP formation to the amount of CYP2D6 present in Supersomes (nmol/nmol) was found to be 0.23 (ratio of first trial ϭ 0.24 and ratio of second trial ϭ 0.22). On the other hand, N-alkylPP formation after TTMS and 4-ethyl DDC was at the lowest limit of detection of 0.04 nmol, and the ratio of both N-vinylPP and N-ethylPP to the amount of CYP2D6 was found to be 0.08. We are unable to compare these results with P450s in rat liver since no CYP2D6 orthologs are present in rat liver.
When 0.5 mM TTMS, 1.0 mM 4-ethyl DDC, or AIA (1.0 or 10 mM) were incubated, in the presence of NADPH, with Supersomes possessing cDNA-expressed human CYP3A4, TTMS and AIA elicited N-vinylPP and N-AIAPP formation, respectively, but 4-ethyl DDC did not elicit N-ethylPP formation (Figs. 2 and 3) . The ratio of N-vinylPP formation to the amount of CYP3A4 present in Supersomes (nmol/nmol) was found to be 0.87 (ratio of first trial ϭ 0.85 and ratio of second trial ϭ 0.89), while the ratio of N-AIAPP formation after AIA (10 mM) to the amount of P450 was 0.30 (ratio of first trial ϭ 0.28 and ratio of second trial ϭ 0.32). The results obtained indicate that mechanism-based inactivation of human CYP3A4 by TTMS is associated with prosthetic heme transformation via Nalkylation. The absence of N-ethylPP formation after interaction of 4-ethyl DDC with CYP3A4 is consistent with a report (Correia et al., 
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at ASPET Journals on July 7, 2017 dmd.aspetjournals.org 1987), that mechanism-based inactivation of rat CYP3A2 by 4-ethyl DDC was found to involve fragmentation of the heme moiety to reactive metabolites that irreversibly bind to the P450 apoprotein. It is of interest to compare the above results with those obtained by Wong et al. (1998 Wong et al. ( , 1999a using rat liver microsomes. Thus, TTMS but not 4-ethyl DDC yielded N-alkylPP formation from rat CYP3A2. On the other hand, results obtained for AIA with CYP3A4 did not correspond with those of Wong et al. (1998 Wong et al. ( , 1999a , who did not detect N-alkylPP formation with rat CYP3A2 in liver microsomes (Table 1 ). This finding suggests that there are sufficient differences between the active sites of CYP3A4 and 3A2 to result in different pathways for biotransformation of AIA. An alternative explanation is the difference in the P450 to P450 reductase ratio between the two P450 enzymes, one of which is present in Supersomes and the other in rat microsomes.
A comparison of N-alkylPP formation between Supersomes containing single cDNA-expressed human P450 enzymes (1A2, 2C9, or 3A4) and rat liver (Wong et al., 1998 (Wong et al., , 1999a after treatment with TTMS, 4-ethyl DDC, and AIA can be found in Table 1 control, NADPH omitted (B); and control, ; fluorescence spectra resulting from the incubation of AIA and NADPH with Supersomes containing CYP2D6 (D); control, NADPH omitted (E); control, AIA omitted (F) ; fluorescence spectra resulting from the incubation of TTMS and NADPH with Supersomes containing CYP3A4 (G); control, NADPH omitted (H); control, TTMS omitted (I) . (1A2, 2C9, or 3A4) and rat liver (Wong et al., 1998; Wong and Marks 1999a) at ASPET Journals on July 7, 2017 dmd.aspetjournals.org other hand, the results obtained with 4-ethyl DDC and AIA with human CYP2C9 correspond with those obtained with rat CYP2C11, but this is not the case with TTMS. The differences observed between rat and human P450 enzyme orthologs indicate that it would be useful when dealing with xenobiotics in which porphyrinogenicity depends upon interaction with P450 enzymes accompanied by N-alkylPP formation to supplement animal data with studies using cDNA-expressed individual human P450 enzyme preparations. The advantage of using expression systems in our studies was that the effect of TTMS, 4-ethyl DDC, and AIA on individual P450 enzymes could be determined, without interference by other P450 enzymes. Nevertheless, results obtained with these expression systems may not reflect the overall in vivo effects of these compounds, which is dependent on the specific activity and relative abundance of each P450 enzyme. Moreover, the phospholipid environment, lipid to protein ratio, and NADPH-P450 reductase to P450 ratio can be markedly different between native microsomal systems and cDNAexpressed single P450 enzyme systems (Rodrigues, 1999) . Therefore, our second objective was to determine whether N-alkylPP formation could be detected in human liver microsomes after interaction with xenobiotics in vitro.
When TTMS (0.5 mM) or AIA (10 mM) were incubated with human liver microsomes possessing elevated CYP3A4 (HG112), both TTMS and AIA elicited N-alkylPP formation in an NADPHdependent manner (Figs. 4 and 5) . The amount of N-vinylPP formation from TTMS and N-AIAPP formation from AIA was found to be 0.83 nmol (trial one ϭ 0.91 nmol, trial two ϭ 0.84 nmol, and trial three ϭ 0.73 nmol) and 0.38 nmol (trial one ϭ 0.48 nmol and trial two ϭ 0.28 nmol), respectively. In view of the fact that we obtained both N-vinylPP and N-AIAPP formation from Supersomes possessing only CYP3A4, these results were anticipated. When 4-ethyl DDC or AIA was incubated with human liver microsomes possessing elevated CYP1A2 and 2C9 (HG56), only AIA elicited N-alkylPP formation in an NADPH-dependent manner (Figs. 4 and 5 ). The amount of N-AIAPP formation was found to be 0.37 nmol (trial one ϭ 0.42 nmol and trial two ϭ 0.32 nmol). Given the fact that AIA elicited N-alkylPP formation from Supersomes possessing CYP2C9, these results were anticipated. However, the absence of N-ethylPP formation after the interaction of 4-ethyl DDC with human liver microsomes (HG56) was not anticipated, since N-ethylPP formation was observed with Supersomes containing either CYP1A2 or 2C9. A possible explanation for this result is the following: although these human liver microsomes (HG56) contain elevated CYP1A2 and 2C9, they also contain 0.62 FIG. 4 . N-Alkyl formation after the incubation of TTMS and AIA with human liver microsomes (HG112) and 4-ethyl DDC and AIA with human liver microsomes (HG56).
Data are expressed in units as indicated and each bar represents the mean of two or three experiments. Individual values are given under Results and Discussion.
FIG. 5. Fluorescence spectra resulting from the incubation of TTMS and NADPH with human liver microsomes (HG112) (A); control, NADPH omitted (B); control, TTMS omitted (C); fluorescence spectra resulting from the incubation of AIA and NADPH with human liver microsomes (HG56) (D); control, NADPH omitted (E);
control, AIA omitted (F).
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at ASPET Journals on July 7, 2017 dmd.aspetjournals.org Downloaded from nmol or 12.5% CYP3A4. Moreover, 4-ethyl DDC caused mechanismbased inactivation of rat CYP3A2, which is not accompanied by N-alkylPP formation (Correia et al., 1987) . Thus the major portion of 4-ethyl DDC may undergo biotransformation by CYP3A4 diverting the xenobiotic from CYP1A2 and CYP2C9. In summary, we have achieved our primary goal and have developed an in vitro test system for the isolation and detection of NalkylPPs, which are produced in the human liver after the administration of xenobiotics, previously found to be porphyrinogenic in one or several animal species. Fluorometry was found to be a sensitive method to 1) determine which specific P450 enzymes in Supersomes were the source of N-alkylPP formation and to 2) detect N-alkylPP formation in human liver microsomes after interaction with xenobiotics in vitro. We have shown that some differences exist between human liver P450 enzymes and their rat orthologs with respect to N-alkylPP formation following mechanism-based inactivation by porphyrinogenic xenobiotics. It would therefore be prudent when dealing with xenobiotics in which porphyrinogenicity depends upon interaction with P450 enzymes and N-alkylPP formation to supplement animal data with studies in human liver microsomes and cDNAexpressed individual P450 enzyme preparations. This would be particularly important where xenobiotics are shown to be porphyrinogenic due to the production of N-alkylPPs in the livers of some animal species but not others (Frater et al., 1993) .
